Oncolytic virus in gliomas: a review of human clinical investigations
- PMID: 33771666
- DOI: 10.1016/j.annonc.2021.03.197
Oncolytic virus in gliomas: a review of human clinical investigations
Abstract
Gliomas remain one of the more frustrating targets for oncologic therapy. Glioma resistance to conventional therapeutics is a product of their immune-privileged milieu behind the blood-brain barrier, in addition to their suppressive effect on the immune response itself. Taking the lead from the growing success of immunotherapy for systemic cancers, such as lung cancer and melanoma, immunotherapeutics has emerged as a major player in the potential treatment of gliomas, with oncolytic viruses in particular showing significant promise as evidenced by the recent Breakthrough and Fast Tract Designations for PVSRIPO and DNX2401. This review serves as a useful and updated compendium of the completed human clinical investigations for several oncolytic viruses in the treatment of gliomas.
Keywords: glioma; immunotherapy; oncolytic virus.
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Similar articles
-
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.Front Immunol. 2021 Oct 5;12:721830. doi: 10.3389/fimmu.2021.721830. eCollection 2021. Front Immunol. 2021. PMID: 34675919 Free PMC article. Review.
-
Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.Int Rev Cell Mol Biol. 2023;379:169-188. doi: 10.1016/bs.ircmb.2023.04.001. Epub 2023 Apr 26. Int Rev Cell Mol Biol. 2023. PMID: 37541723 Review.
-
Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):103-17. doi: 10.1016/j.cytogfr.2010.04.001. Epub 2010 May 18. Cytokine Growth Factor Rev. 2010. PMID: 20483653 Review.
-
[Oncolytic viruses for therapy of malignant glioma].Biomed Khim. 2016 May;62(4):376-90. doi: 10.18097/PBMC20166204376. Biomed Khim. 2016. PMID: 27562991 Review. Russian.
-
Oncolytic Virotherapy in Glioma Tumors.Int J Mol Sci. 2020 Oct 14;21(20):7604. doi: 10.3390/ijms21207604. Int J Mol Sci. 2020. PMID: 33066689 Free PMC article. Review.
Cited by
-
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.Front Immunol. 2021 Oct 5;12:721830. doi: 10.3389/fimmu.2021.721830. eCollection 2021. Front Immunol. 2021. PMID: 34675919 Free PMC article. Review.
-
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice.Pathogens. 2023 Jun 22;12(7):861. doi: 10.3390/pathogens12070861. Pathogens. 2023. PMID: 37513708 Free PMC article. Review.
-
TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.Clin Transl Sci. 2023 Oct;16(10):1957-1971. doi: 10.1111/cts.13604. Epub 2023 Aug 10. Clin Transl Sci. 2023. PMID: 37503932 Free PMC article.
-
Glioblastoma vaccines: past, present, and opportunities.EBioMedicine. 2024 Feb;100:104963. doi: 10.1016/j.ebiom.2023.104963. Epub 2024 Jan 5. EBioMedicine. 2024. PMID: 38183840 Free PMC article. Review.
-
Genome-wide analysis of circulating tumor DNA methylation profiles in cerebrospinal fluid: a clinical trial of oncolytic virus for glioblastoma.Am J Cancer Res. 2023 Dec 15;13(12):5950-5965. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187045 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical